Preclinical pharmacology and pharmacokinetics of the anti-hepatitis virus agent 2'-fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil in mice and rats.

The preclinical pharmacology and pharmacokinetics of 2'-fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil (FEAU), a selective inhibitor of herpesvirus and hepatitis virus replication, were investigated in the mouse and rat. Following intravenous (i.v.) or oral (p.o.) administration, FEAU was cleared fr...

Ful tanımlama

Detaylı Bibliyografya

Yayımlandı:	Antimicrob Agents Chemother
Asıl Yazarlar:	Kong, X B, Vidal, P, Tong, W P, Chiang, J, Gloff, C A, Chou, T C
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	American Society for Microbiology (ASM) 1992
Konular:	Research Article
Online Erişim:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC191606/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1510443/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.7.1472
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!